Orexin receptor antagonists for major depressive disorder: perspectives from a systematic review and meta-analysis

研究成果: ジャーナルへの寄稿 › Letter › 査読

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

@article{2908b98b327140a6b986b481ead0043c,

title = "Orexin receptor antagonists for major depressive disorder: perspectives from a systematic review and meta-analysis",

author = "Taro Kishi and Kenji Sakuma and Masakazu Hatano and Shun Hamanaka and Yasufumi Nishii and Nakao Iwata",

year = "2026",

doi = "10.1038/s41380-026-03599-z",

language = "English",

journal = "Molecular Psychiatry",

issn = "1359-4184",

publisher = "Springer Nature",

}

TY - JOUR

T1 - Orexin receptor antagonists for major depressive disorder

T2 - perspectives from a systematic review and meta-analysis

AU - Kishi, Taro

AU - Sakuma, Kenji

AU - Hatano, Masakazu

AU - Hamanaka, Shun

AU - Nishii, Yasufumi

AU - Iwata, Nakao

PY - 2026

Y1 - 2026

UR - https://www.scopus.com/pages/publications/105035035342

UR - https://www.scopus.com/pages/publications/105035035342#tab=citedBy

U2 - 10.1038/s41380-026-03599-z

DO - 10.1038/s41380-026-03599-z

M3 - Letter

AN - SCOPUS:105035035342

SN - 1359-4184

JO - Molecular Psychiatry

JF - Molecular Psychiatry

ER -